Dr. Tina J. Falika King, MD, MPH

Media Releases

Get to know Obstetrician-Gynecologist Dr. Tina J. Falika King, who serves patients in Annandale, Virginia.

A caring and compassionate obstetrician-gynecologist who has been in practice since 2009, Dr. King joined Inova Health System in 2020.

In addition to seeing patients at Inova Medical Group OBGYN – Annandale, she is affiliated with Inova Alexandria Hospital and Inova Fairfax Hospital.

In her line of work, Dr. King has a special interest in management of high-risk pregnancy, fibroids, fertility, uterine problems and treatment as well as overall women’s health. She hopes to further cultivate her passion for patient education with a patient-centered approach to women’s healthcare as well as OB-GYN resident education. 

A native of Northern Virginia, Dr. King graduated with her Medical Degree from The Ohio State University College of Medicine in 2009. Upon completion of her general OB-GYN training at WellSpan York Hospital, she obtained additional high-risk obstetrics training with the perinatal team at Inova Fairfax Hospital. She also completed a Master of Public Health Degree in Clinical Investigations.

Board certified in obstetrics and gynecology, the doctor is a Diplomate of the American Board of Obstetrics and Gynecology (ABOG). The mission of the ABOG is to define standards, certify obstetricians and gynecologists, and facilitate continuous learning to advance knowledge, practice, and professionalism in women’s health.

Prior to joining Inova, Dr. King worked in private practice in Alexandria, Virginia.

Obstetrics and Gynecology is the medical specialty that encompasses the two subspecialties of obstetrics and gynecology. An obstetrician-gynecologist, or OB-GYN, is a healthcare professional who specializes in female reproductive health.

Outside of practicing medicine, Dr. King is very excited to remain in the Northern Virginia area to raise her family with her husband, Aaron.

Recommended Articles

• Single Embryo Transfers Are Safer for Having Healthy a Baby

  According to an international study published in the journal BMJ, women who have single embryo transfer rather than double embryo transfer have more chances of having a full-term pregnancy in in vitro fertilization. This study was a review of medical literature carried out by D.J. McLemon, an...

• What Are The Side Effects Of Bariatric Surgery?

  Bariatric surgery is also referred to as weight loss surgery. In other cases, it is known as gastric bypass surgery. It is an operation performed mostly on obese people. The main purpose for this type of surgery is to reduce weight.Bariatric surgery involves the removal of certain portions of your...

• All About Metronidazole

  Metronidazole gel is employed in the treatment of certain vaginal bacterial infections such as bacterial vaginosis. The drug in its other forms can also be used to treat other illnesses as may be advised by your healthcare provider.It is part of a class of medications referred to as nitroimidazole...

• Antidepressants Taken During Pregnancy can Raise the Risk of Lung Conditions in Newborns

  Some of the popular antidepressants used during pregnancy may raise the risk of a rare but serious lung condition in newborns, according to a new report. In this study, researchers analyzed the data of almost 1.6 million births in five Nordic countries available at the national registry. The...

• Track Your Baby's Development Week by Week in the Second Trimester

  Growth and development happens swiftly during the second trimester. The baby continues to change and develop almost daily.During this stage, the focus of development is to increase in size and weight. In addition, the umbilical cord continues to thicken as it carries nutrients to the fetus. The baby...

• Sleep Positioners May Increase a Baby's Risk of Death

  A warning has been issued by the FDA and the Consumer Product Safety Commission (CPSC) against the use of sleep-positioning devices for babies. About 12 deaths have been reported with the use of these devices in the last 13 years.FDA principal deputy commissioner, Joshua Sharfstein, reported that...